Ubtech Robotics Faces Mounting Pressure in Humanoid Robot Race

Ubtech Robotics shares fall to 52-week low as it scales production for 2026 target, acquires stake in Fenglong, and faces projected losses.

The competition to achieve mass production of humanoid robots is entering a critical stage. For Ubtech Robotics, this period is marked by significant financial strain as it works to scale its operations, a challenge reflected in its recent stock performance.

Shares of the company recently closed at a 52-week low of exactly 9.98 euros, cementing a year-to-date decline of more than 31 percent. This downward trend underscores the market's reaction to the costly balancing act between scaling production and pursuing strategic acquisitions.

Scaling Up Amidst Fierce Competition

The industry is shifting from technical prototyping to commercial manufacturing, where volume and cost efficiency are becoming the key determinants of leadership. Recent sector reports highlight that competitor Zhipu Robotics has already celebrated a major milestone: the production of its 10,000th humanoid robot. This achievement places direct scrutiny on Ubtech's own roadmap. The company's CEO, Zhou Jian, has publicly targeted the exact same production goal—10,000 units—for the calendar year 2026.

Financing the Ambition

To fund this ambitious target and solidify its market position, Ubtech's management is deploying substantial capital. In a recent strategic move, the company initiated a partial tender offer to acquire a 13.02 percent stake in Fenglong Co., Ltd., a Shenzhen-listed firm. The transaction is estimated to require approximately 504 million renminbi and is intended to strengthen Ubtech's control over the target company.

Further bolstering its financial flexibility, shareholders approved expanded bank credit lines at an extraordinary general meeting in mid-March. These new financing avenues are deemed essential to support the capital-intensive ramp-up of its industrial robot manufacturing capabilities.

Upcoming Results and Projected Losses

Attention now turns to the board's upcoming release of the fiscal year 2025 annual results, scheduled for Tuesday, March 31. The announcement will also include a decision on a potential dividend. Market analysts anticipate a loss of about $0.90 per share, highlighting the persistently high research and development costs associated with bringing its robotic technology to market.